![Jean-Michel Cossery](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jean-Michel Cossery
Ordförande på
SCANCELL HOLDINGS PLC
Förmögenhet: 2 M $ per 2026-08-31
Profil
Dr. Jean-Michel Y.
Cossery is a Non-Executive Chairman at Scancell Holdings Plc, an Independent Director at SOPHiA GENETICS SA and an Independent Non-Executive Director at Malin Corp.
Plc.
He is on the Board of Directors at SOPHiA GENETICS SA, Malin Corp.
Plc and Malin Life Sciences Holdings Ltd. Dr. Cossery was previously employed as a Non-Executive Director by Diurnal Group Ltd., a Non-Executive Director by Immunocore Holdings Plc, a Non-Executive Director by Kymab Ltd., a Vice President-North American Oncology by Eli Lilly & Co., a Chief Marketing Officer & VP-Global Marketing by GE Healthcare Ltd. (United Kingdom), a Chairman by American Pharmaceutical Group, an Executive Vice President-Global Marketing by Amersham Health, a Principal by EMD Serono, Inc., and a Principal by Novartis, Inc. He also served on the board at EraCal Therapeutics AG, Diurnal Ltd., EXACT Therapeutics AS, Immunocore Ltd., Kymab Group Ltd., The Association of the British Pharmaceutical Industry and Wipro GE HealthCare Pvt Ltd. He received his MBA from Rotterdam School of Management and a doctorate degree from Université Paris-Saclay.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
SOPHIA GENETICS SA 0,25 % | 2026-06-18 | 206 212 ( 0,25 % ) | 2 M $ | 2026-08-31 |
SCANCELL HOLDINGS PLC 0,04 % | 2025-04-30 | 454 545 ( 0,04 % ) | 60 086 $ | 2026-08-31 |
MALIN CORPORATION PLC 0,07 % | 2025-03-21 | 2 861 ( 0,07 % ) | 23 263 $ | 2026-08-31 |
Aktiva positioner av Jean-Michel Cossery
| Företag | Position | Start |
|---|---|---|
| MALIN CORPORATION PLC | Direktör/Styrelseledamot | 2018-07-16 |
| SOPHIA GENETICS SA | Direktör/Styrelseledamot | 2022-06-15 |
| SCANCELL HOLDINGS PLC | Ordförande | 2023-02-01 |
Malin Life Sciences Holdings Ltd.
 Malin Life Sciences Holdings Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Direktör/Styrelseledamot | - |
Tidigare kända positioner av Jean-Michel Cossery
| Företag | Position | Slut |
|---|---|---|
EraCal Therapeutics AG
 EraCal Therapeutics AG BiotechnologyHealth Technology Engages in research and development of biotechnology | Direktör/Styrelseledamot | 2024-02-01 |
| EXACT THERAPEUTICS | Direktör/Styrelseledamot | 2023-06-01 |
| DIUL GROUP | Direktör/Styrelseledamot | 2022-10-01 |
Diurnal Ltd.
 Diurnal Ltd. Pharmaceuticals: MajorHealth Technology Develops hormone therapeutics | Direktör/Styrelseledamot | 2022-10-01 |
Kymab Group Ltd.
 Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops human monoclonal antibody drugs | Direktör/Styrelseledamot | 2021-04-01 |
Jean-Michel Cosserys utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
72
Första gradens relationer
22
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 22 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Novartis, Inc.
 Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco, CA. | Health Technology |
American Pharmaceutical Group | |
Malin Corp. Plc
 Malin Corp. Plc BiotechnologyHealth Technology Provides life science services | Health Technology |
GE Healthcare Ltd. (United Kingdom)
 GE Healthcare Ltd. (United Kingdom) Medical SpecialtiesHealth Technology Provides transformational medical technologies and services | Health Technology |
EMD Serono, Inc.
 EMD Serono, Inc. BiotechnologyHealth Technology Develops therapeutics and drug delivery devices for neurology, oncology & immunology | Health Technology |
Amersham Health | |
The Association of the British Pharmaceutical Industry
 The Association of the British Pharmaceutical Industry Miscellaneous Commercial ServicesCommercial Services Operates pharmaceutical companies associations | Commercial Services |
Diurnal Group Ltd.
 Diurnal Group Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and commercializes therapeutics for neuropsychiatric, neurological & neuroendocrine disorders | Health Technology |
Scancell Holdings Plc
 Scancell Holdings Plc BiotechnologyHealth Technology Develops therapeutic cancer vaccines | Health Technology |
Wipro GE HealthCare Pvt Ltd.
 Wipro GE HealthCare Pvt Ltd. Information Technology ServicesTechnology Services Operates as a information technology, consulting and outsourcing company | Technology Services |
Kymab Ltd.
 Kymab Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops human monoclonal antibody drugs | Health Technology |
Rotterdam School of Management
 Rotterdam School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SOPHiA GENETICS SA
 SOPHiA GENETICS SA Packaged SoftwareTechnology Services Develops software services for healthcare industry | Technology Services |
Diurnal Ltd.
Diurnal Ltd. Pharmaceuticals: MajorHealth Technology Develops hormone therapeutics | Health Technology |
Malin Life Sciences Holdings Ltd.
Malin Life Sciences Holdings Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
EXACT Therapeutics AS
 EXACT Therapeutics AS BiotechnologyHealth Technology Develops technology platform for targeted drug delivery | Health Technology |
EraCal Therapeutics AG
EraCal Therapeutics AG BiotechnologyHealth Technology Engages in research and development of biotechnology | Health Technology |
Kymab Group Ltd.
Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops human monoclonal antibody drugs | Health Technology |
Université Paris-Saclay
 Université Paris-Saclay Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immunocore Holdings Plc
 Immunocore Holdings Plc BiotechnologyHealth Technology Operates as a biotechnology company which develops immunotherapies | Health Technology |
Immunocore Ltd.
 Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes transformative medicines for cancer, infection and autoimmune disease | Health Technology |
